Isolating fetal erythroblasts from maternal blood offers a promising noninvasive alternative for prenatal diagnosis. The current immunoenzymatic methods of identifying fetal cells from background maternal cells postenrichment by labeling ␥-globin are problematic. They are nonspecific because maternal cells may produce ␥-globin, give poor hybridization efficiencies with chromosomal fluorescence in situ hybridization (FISH), and do not permit simultaneous visualization of the fetal cell identifier and the FISH signal. We describe a novel technique that allows simultaneous visualization of fetal erythroblast morphology, chromosomal FISH, and ⑀-globin labeled with AMCA (7-amino-4-methylcoumarin-3-acetic acid).AMCA was chosen as the fluorescent label to circumvent the problem of heme autofluorescence because the mean difference in relative fluorescence intensity between fetal erythroblasts stained positive for antiglobin antibody and autofluorescence of unstained cells was greater with AMCA (mean 43.2; 95% confidence interval [CI], 34.6-51.9; SD ؍ 14.0) as the reporting label compared with fluorescein isothiocyanate (mean 24.2; 95% CI, 16.4-31.9; SD ؍ 12.4) or phycoerythrin (mean 9.8; 95% CI, 4.8-14.8; SD ؍ 8.0). Median FISH hybridization efficiency was 97%, comparable to the 98% (n ؍ 5 paired samples) using Carnoy fixative. One ⑀-positive fetal erythroblast was identified among 10 5 maternal nucleated cells in 6 paired mixture experiments of fetal erythroblasts in maternal blood (P < .001). Male ⑀-positive fetal erythroblasts were clearly distinguishable from adult female ⑀-negative erythroblasts, with no false positives (n ؍ 1000). The frequency of fetal erythroblasts expressing ⑀-globin declines linearly from 7 to 14 weeks' gestation (y ؍ ؊15.8 ؋ ؉ 230.8; R 2 ؍ 0.8; P < .001). We describe a rapid and accurate method to detect simultaneously fetal erythroblast morphology, intracytoplasmic ⑀-globin, and nuclear FISH.
IntroductionIsolating fetal nucleated red blood cells (NRBCs) from maternal blood should allow first trimester noninvasive prenatal diagnosis of aneuploidy and monogenic disorders. 1 There are currently 3 steps: enrichment of fetal cells in maternal blood, identification of fetal cells among background maternal cells, and diagnosis using fluorescence in situ hybridization (FISH) or single-cell techniques. Antibody directed against the ␥ chain of fetal hemoglobin is commonly used for both the fetal cell enrichment 2,3 and identification 4 steps. There may be a case for using ␥-globin for sorting, favoring yield over purity, but it is not nearly specific enough for accurate fetal erythroblast identification because of increased maternal fetal hemoglobin production in pregnancy 5 and  thalassemia. 6,7 In contrast, ⑀-or -globin chains appear specific for fetal cells in chorionic villus supernatants 7 but have not been tested in maternal blood. Whereas -globin is occasionally produced in adults with ␣ thalassemia, 8 ⑀-globin has not been found in adult peripheral blood, 9 making it the prefer...